telbivudine
J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AF - Nucleoside And Nucleotide Reverse Transcriptase Inhibitors -> J05AF11 - Telbivudine
Administration category:
Free
Medicine group:
antiviral
Brand name:
Sebivo
Standard dosages
| Weight | ROA | Load | Dosage |
|---|---|---|---|
|
ROA: po |
Load: - |
Dosage: 600mg 1 dd |
Kidney function
| ROA | GFR | Dosage | Interval | Comments |
|---|---|---|---|---|
| ROA: po | ||||
|
GFR: 30 - 50 |
Interval: 48 Hours |
|||
|
GFR: <30 |
Interval: 72 Hours |
|||
Renal elimination:
100%
Dosage:
dependent on kidney function
Renal function-replacement therapy
CAPD: gebruik vermijden vanwege het ontbreken van gegevens
Hemo dialysis: 120 mg elke 24 uur, op dialysedagen toedienen na dialyse
CAV / VVHD: 200 mg elke 24 uur (drank) OF 600 mg elke 72 uur (tablet)
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-2035.2
Updated: 06/16/2019 - 20:05
Status: Published